Recruiting Safety and Efficacy of ONT01 in Lupus NCT07107659 Conditions Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +19 more Locations Hospital for Special Surgery — New York, United States View Trial Details
Active, Not Recruiting KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis NCT05938725 Conditions Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more Locations Stanford University Medical Center — Palo Alto, California, United States University of Colorado — Denver, Colorado, United States University of Massachusetts Worcester — Worcester, Massachusetts, United States Northwell Health — Great Neck, New York, United States View more locations Show fewer locations Loading locations... View Trial Details
